Cargando…

Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?

INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is a genetically heterogeneous disease often diagnosed with synchronous metastatic disease involving the liver. Tumors with extra‐abdominal spread that bypass the liver are thought to represent a unique molecular subgroup and those with isolated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebrahimi, Aren, Cham, Jason, Puglisi, Leah, De Shadarevian, Melanie, Hermel, David J., Spierling Bagsic, Samantha R., Sigal, Darren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225201/ https://www.ncbi.nlm.nih.gov/pubmed/36916531 http://dx.doi.org/10.1002/cam4.5751

Ejemplares similares

An observational study of hospitalized COVID-19 patients with cancer in San Diego county
por: Hermel, David J, et al.
Publicado: (2022)

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients
por: Botta, Gregory P., et al.
Publicado: (2022)

ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients
por: Hermel, David J, et al.
Publicado: (2021)

The Novel Concept of Patient Self-Imaging: Success in COVID-19 and Cardiopulmonary Disorders
por: Resnikoff, Pamela M., et al.
Publicado: (2021)

Simplified Lung Ultrasound Examination and Telehealth Feasibility in Early SARS-CoV-2 Infection
por: Kimura, Bruce J., et al.
Publicado: (2022)

The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
por: Hermel, David J., et al.
Publicado: (2019)

Actigraphy-based sleep and activity measurements in intensive care unit patients randomized to ramelteon or placebo for delirium prevention
por: Jaiswal, Stuti J., et al.
Publicado: (2023)

Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review
por: Cham, Jason, et al.
Publicado: (2021)

Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting
por: Fortmann, Addie L., et al.
Publicado: (2020)

UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center
por: Kurian, Sunil M., et al.
Publicado: (2021)

COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego
por: Quiroz, Elisa, et al.
Publicado: (2020)

Metastatic Pancreatic Adenocarcinoma During Pregnancy
por: Davis, Jessica, et al.
Publicado: (2016)

Metastatic Pancreatic Adenocarcinoma to Umbilical Skin
por: Aghighi, Maryam, et al.
Publicado: (2022)

Pancreatic adenocarcinomas with mature blood vessels have better overall survival
por: Katsuta, Eriko, et al.
Publicado: (2019)

A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
por: Wang, Yi, et al.
Publicado: (2018)

ABO/Rh Blood Group and COVID-19 Infection Severity
por: Hermel, David J, et al.
Publicado: (2020)

MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
por: Maddipati, Ravikanth, et al.
Publicado: (2022)

Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma
por: Hermel, David J., et al.
Publicado: (2021)

Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis
por: Yang, Anthony, et al.
Publicado: (2021)

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016)

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
por: Park, Hyung Soon, et al.
Publicado: (2016)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Metastatic Pancreatic Adenocarcinoma Presenting as a Klatskin Tumor
por: Munis, Assad, et al.
Publicado: (2018)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020)

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma
por: Huffman, Brandon M., et al.
Publicado: (2022)

Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
por: Rémond, M.S., et al.
Publicado: (2022)

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
por: O'Reilly, Eileen M., et al.
Publicado: (2020)

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
por: Li, Wanwan, et al.
Publicado: (2019)

What are the macrophages and stellate cells doing in pancreatic adenocarcinoma?
por: Pandol, Stephen J., et al.
Publicado: (2015)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
por: Péron, Julien, et al.
Publicado: (2016)

Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020)

Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
por: Grzelak, Doreen
Publicado: (2021)

Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
por: Lellouche, Lisa, et al.
Publicado: (2021)

Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
por: Gautam, Shailendra K., et al.
Publicado: (2023)

Mi Puente (My Bridge) Care Transitions Program for Hispanic/Latino Adults with Multimorbidity: Results of a Randomized Controlled Trial
por: Gallo, Linda C., et al.
Publicado: (2023)

Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2021)

Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
por: Fulop, Daniel J., et al.
Publicado: (2023)

Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
por: Gallo, Graziana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tlv5ectjra1l6r8r7pjj79pi8i